Ace the SOCRA CCRP Exam 2026 – Become a Clinical Superstar!

The FDA has various programs used to monitor drugs, biologics, and medical devices. Out of the options provided, the Bioresearch Monitoring program (BIMO) is the correct answer. This program specifically focuses on monitoring and inspecting clinical trials to ensure the safety, efficacy, and compliance of new drugs and medical devices.

The other options are incorrect because

- Option A, FDA Biomedical Research Program, is not a specific program name for monitoring and inspecting clinical trials. It is a broader term that encompasses all of the FDA's biomedical research efforts.

- Option C, Clinical Trial Surveillance Program, is not the correct name for the FDA's monitoring program. This is because the FDA's monitoring program for clinical trials is called the Bioresearch Monitoring program, as mentioned earlier.

- Option D, FDA Oversight and Compliance Program, is also not the correct name for the